http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-042467-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 |
| filingDate | 2003-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-042467-A1 |
| titleOfInvention | 5H-PIRROLO COMPOUNDS [2,1-C] [1,4] BENZODIAZEPIN BIOLOGICALLY ACTIVE VASOPRESIN AGONISTS |
| abstract | This refers to compounds of the formula (1) where W represents either an O linked by double bond or two H linked by simple bond; R1 is selected from the group consisting of R, R3-X-R2-, R3-S (O) -, R3-S (O) 2-, -SO3R4, -S (O) 2N (R) 2, and D- glucuronidate, when W is H. O R1 is selected from the group consisting of H, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, and heteroarylalkyl, when W is O; R2 is selected from the group consisting of alkylene, cycloalkylene, alkylene-X-alkylene, alkylene-X-cycloalkylene, cycloalkylene-X-alkylene, and cycloalkylene-X-cycloalkylene; R3 is selected from the group consisting of alkyl, aryl, heteroaryl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, alkenyl-X-alkylene, cyclooalkenyl-X-alkylene, and perfluoroalkyl; R4 is selected from the group consisting of H and R3; R3 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, monofluoroalkyl, perfluoroalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, hydroxyalkyl (C1-6), alkoxyalkyl, alkylthioalkyl, acyl, alkoxy -C (O) NH2, alkylaminocarbonyl, dialkylaminocarbonyl, alkylaminoalkyl, and dialkylaminoalkyl, and when two R groups are attached to the same atom these two groups together can form an alkylene group; X is selected from the group consisting of O, -NR-, -S (O) m-, -C (O) -, -OC (O) -, -C (O) O-, -NRC (O) - , and -C (O) NR-; and m is an integer selected from 0, 1, and 2, and the racemates, enantiomers, and pharmaceutically acceptable salts thereof, a process for their manufacture and the pharmaceutical formulations containing said compounds which are useful as anti- agents. aquatics in the treatment of nocturnal urinary enuresis, nocturnal urinary emergency, and / or similar conditions. |
| priorityDate | 2002-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148431 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574411 |
Total number of triples: 20.